CIK: 1731193 - Address: C/O Cullinan Therapeutics, Inc., One Main Street, Suite 1350, Cambridge, MA 02142
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/25/26 17:00
2/24/26
CGEMCullinan Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagAhmed NadimMADOP,CEOS-19614.470-14-3391D
2/23/26 17:00
2/20/26
CGEMCullinan Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagAhmed NadimMADOP,CEOS-22313.620-16-4404D
12/29/25 17:00
12/23/25
CGEMCullinan Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagAhmed NadimMADOP,CEOS-9910.010-10-2421D
2/27/25 17:00
2/25/25
CGEMCullinan Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagAhmed NadimMADOP,CEOS-1078.530-13-3431D
12/27/24 18:00
12/24/24
CGEMCullinan Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagAhmed NadimMADOP,CEOS-10011.870-8-3263D
12/27/23 18:30
12/26/23
CGEMCullinan Oncology, Inc.HealthBioPrdBiological Products, (No DiagAhmed NadimMADOP,CEOS-399.240-4-4112D
6/29/23 16:59
6/28/23
CGEMCullinan Oncology, Inc.HealthBioPrdBiological Products, (No DiagAhmed NadimMADOP,CEOS-911.400-1-1116D
5/24/23 16:36
5/23/23
CGEMCullinan Oncology, Inc.HealthBioPrdBiological Products, (No DiagAhmed NadimMADOP,CEOS-69.150-1-1117D
4/26/23 16:23
4/25/23
CGEMCullinan Oncology, Inc.HealthBioPrdBiological Products, (No DiagAhmed NadimMADOP,CEOS-810.590-1-1117D
3/27/23 16:05
3/23/23
CGEMCullinan Oncology, Inc.HealthBioPrdBiological Products, (No DiagAhmed NadimMADOP,CEOS-710.510-1-1118D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact